
Avidity Biosciences Investor Relations Material
Latest events

Study Update
Avidity Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avidity Biosciences Inc
Access all reports
Avidity Biosciences Inc is a biopharmaceutical company focused on developing a novel class of RNA therapeutics. These therapeutics, known as Antibody Oligonucleotide Conjugates (AOC™), are designed to target and treat a range of serious diseases by combining the specificity of monoclonal antibodies with the precision of oligonucleotides. This approach aims at addressing diseases previously untreatable with RNA therapeutics. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Key slides for Avidity Biosciences Inc


Study Update
Avidity Biosciences Inc


Investor Update
Avidity Biosciences Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
RNA
Country
🇺🇸 United States